Clinical trial
Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?
NCT00164801 · Chinese University of Hong Kong, Other · Terminated
Key facts
| NCT number | NCT00164801 |
|---|---|
| Title | Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese? |
| Official title | Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pain in Chinese? Part 2: Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP Patients |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Non-Cardiac Chest Pain |
| Intervention type | Drug |
| Interventions | Baclofen, Diltiazem |
| Enrollment | 60 |
| Start date | Nov 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Mar 26, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: